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DENGUE IN AN ELDERLY PATIENT
Milton Luiz GORZONI(1), Irineu Francisco Delfino Silva MASSAIA(2) & Sueli Luciano PIRES(1)
SUMMARY
Although elderly populations are more exposed to the risk of getting dengue, the clinical peculiarities of this disease in this age 
range are not well known. This report is about an 80-year-old woman with dengue complications, self-medicated with salicylate. 
Literature indicates a more severe clinical condition, high hospitalization rate and significant mortality. This is caused by previous 
infections by other serotypes of this arbovirus, presence of chronic diseases, immunosenescence and high drug consumption, especially 
salicylates and the like. Analyses are required in a public health perspective in order to help health professionals that care for patients 
with dengue in this age range. 
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INTRODUCTION
Dengue, a feverish acute disease caused by Flavivirus, is among 
the most frequent arboviruses in tropical regions. Nowadays, four 
antigenically different kinds of serotype (DEN-1 to 4) are known, and 
their main vector, the Aedes aegypti, presents great adaptability to urban 
environments. Dengue’s clinical scope ranges from non-specific and 
benign virus syndromes to severe and fatal conditions with hemorrhagic 
displays and shock. The risk of developing a higher clinical severity is 
related to the type of infecting strain, the patient’s genetics and immunity, 
co-morbidities and previous infections with other dengue serotypes. The 
presence of different serotypes at the same time, as has been the case in 
Brazil since 2001, increases the presence of more severe clinical forms 
of the disease. Regardless of the region, dengue epidemics cause a high 
number of cases and deaths yearly8,25,31,33.
Dengue strikes all ages, and its peculiarities in clinical situations and 
its complications related to the elderly are not well known. An internet 
search made in July 2008 with the keywords “Dengue” and “Elderly” in 
MEDLINE (http://www.nlm.nih.gov) and in Scientific Electronic Library 
Online - SciELO (http://www.scielo.br) found, among 740 articles, only 
nine studies which focused on or had notes related to patients over 60 
years of age10,13-15,20,21,24,32,39. The study by GARCIA-RIVERA & RIGAU-
PEREZ10 (2003) is the only one which reported clinical aspects of dengue 
in the elderly. This study observed a prevalence of 4.65% of patients who 
were 65 years old or over in 17,666 cases of dengue, and concluded that 
the elderly had a higher risk of complications, hospitalization and death.
Another search performed on the same internet sites, during the 
same period, with the keywords “Dengue” and “Acetylsalicylic acid” 
found, among 10 articles, two case reports of complications caused by 
the use of acetylsalicylic acid in adults, both of whom were under 60 
years of age16,34. 
As shown in this case report, more clinical studies into dengue and the 
elderly are needed, especially ones mentioning the risk of complications 
related to the use of drugs that can potentially cause hemorrhages. 
CASE REPORT
E.C.G., 84 year-old female, widow, retired, born in the city of São 
Paulo, living in Ubatuba for two years.
Treated by the Geriatrics Out-Patient Department since April 17, 
2001 due to a depressive condition, arterial hypertension, osteoarthritis, 
intestinal constipation, cerumen, and recurrent dizziness. In her clinical 
follow-up, she presented many episodes of falls and developed urine 
incontinence. She was medicated with anti-depressant, benzodiazepine, 
anti-hypertensive, and tiazine drugs. She did not use salicylate due 
to its association to the appearance of epigastralgy. She mentioned 
that she had had a sudden fever on August 02, 2006, which was not 
measured, related to a strong holocranial cephalea, chills, and asthenia, 
followed by nausea and vomiting. She looked for assistance at the local 
emergency room (ER) the following day, where she was re-hydrated 
and discharged on the same day, with a partial improvement of the 
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symptoms. Due to the persistence of cephalea, the patient took 500 
mg salicylate tablets for at least two days after being discharged from 
the ER. Because she still exhibited symptoms, she went to São Paulo 
(to stay with a relative), where skin and eye lesions appeared, which 
led her to look for another medical service. She also mentioned that 
her housekeeper had similar symptoms. When she was admitted to the 
hospital on August 09, 2006, she was conscious, lucid, shivering, with 
bilateral hyphema, bruises on the upper limbs, and petechias on the 
lower limbs. Her blood pressure was 110/70 mmHg, with heart rate of 
78 bpm, axillary temperature of 36.0 °C. Tourniquet test results were 
positive. Thorax without abnormalities and palpable spleen one finger 
below the edge of the costal margin. She was hydrated with a 0.9% 
saline solution, and her temperature ranged from 36.0 °C to 36.5 °C, 
presenting symptoms as shown in lab results given in Table 1 during 
hospitalization and further clinical follow-up. She was discharged from 
the hospital on August 13, 2006 with no complications. On her being 
discharged, the patient’s relatives mentioned that Aedes aegypti had 
been detected in a cemetery near her residence. They also mentioned 
that other dengue cases had been confirmed in the city of Ubatuba, 
including the case of her housekeeper. When returning for her clinical 
follow-up on December 14, 2006, she was informed that the Geriatrics 
Department was interested in publishing her case, where she signed 
the Free Informed Consent Form requested by the Ethics in Human 
Beings Research Committee of the Institution (Project no. 002/07).
DISCUSSION
Recent urbanization of the Brazilian population in the last few 
decades is interfering in the Brazilian demographic pattern. The cities 
present dwellings, employment patterns, and access to information and 
services which promote the reduction of birth and death rates. This is 
causing a progressive inversion of age proportions. It is estimated that 
650,000 Brazilians reach the age of 60 years each year and are included 
in the elderly age range9,36-38.
Aging is becoming a political problem, especially concerning public 
health. This is caused by the high prevalence of chronic diseases in this 
age range and, as a consequence, the simultaneous use of several drugs. 
Thus, there is an increasing risk of hospitalization and/or treatment 
interruption caused by drug interactions and side effects11,12,28.
Vascular diseases, common among the elderly, promote a regular 
prescription of salicylates and the like to patients of this age range 11,28. 
Acute feverish conditions also lead the patients to take the same drugs, 
mostly by self-medication7.
The increase in the aging population and drug consumption along 
with several coinciding dengue outbreaks is a present problem in Brazil. 
Authors have addressed the paradoxical coexistence of dengue - which 
is a disease usually found in underdeveloped regions - and the elderly 
population in a scenario that is compatible with developed areas15,32. Data 
from the Health Department3 states that the dengue incidence rate in 2004 
was 35.00/100,000 inhabitants in Brazil, and 27.09/100,000 in Brazilians 60 
or older. The same source of data shows that in the state of São Paulo, the 
dengue incidence in 2004 was 8.73/100,000 inhabitants in all age ranges, 
and of 7.40/100,000 among the elderly. Although both incidences - in 
Brazil and in the state of São Paulo - present lower figures for the elderly 
than the population in general, there is no statistical significance (p = 2.53 
[Yates]) that differentiates the incidence rates between the two age and/
or geographical ranges. The Injury Report Information System (Sinan, 
Sistema de Informação de Agravos de Notificação) registered 62 dengue 
cases in the city of Ubatuba during 2006, among them five cases of people 
who were 60 years old or over (8.1% of the total cases reported in the city). 
Although this case does not appear in Ubatuba’s statistics because it was 
reported in São Paulo, it is shown in the data of the same source as the only 
case in 2006 of an 80-year old person living in that city5.
Patients with epidemiologies compatible with dengue, presenting 
acute feverish conditions associated with symptoms such as cephalea, 
asthenia, nausea and vomiting, followed by hemorrhagical manifestations 
- spontaneous and with positive tourniquet test results - with minor 
hemodynamic repercussion considering the arterial hypertension 
background, were between groups B and C of the disease stage4. 
Laboratorial confirmation was obtained through the method of choice 
for dengue diagnosis - serology after the sixth day from the onset of 
the symptoms4 - in the case reported, collected on the 9th and 22nd days, 
respectively, with the presence of IgM, and an expressive increase of 
IgG (Table 1). 
It was not possible to report the initial fever degree because the 
temperature of the patient was first measured in the hospital seven 
Table 1
Lab tests in a case of dengue for an elderly woman
Lab test August 9, 2006 August 11, 2006 August 13, 2006 August 24, 2006
Hemogram Erythrocytes 5220000 4650000 4580000
Hemoglobin 14.0 14.0 13.8
Hematocrit 47.0% 41.2% 40.8%
RDW 13.5% 13.2% 13.4%
Leukocytes 2100 4600 5300
Platelets 121000 74000 117000
Seric Sodium 134 134 139
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days after the onset of the symptoms. During that period (one week 
of hospitalization) it was possible to determine the patient’s baseline 
temperature4. However, it is important to mention that people in their 
80’s are more likely to present lower baseline temperatures and lower 
feverish conditions than young adults19,22. The temperature measured 
on the first day of hospitalization was 36.0 °C, compatible with the rule 
proposed by ROGHMANN et al.29 - subtraction of 0.15 °C in baseline 
temperature for each decade after 20 years of age, that is: 36.8 °C - 0.90 
°C (six decades x 0.15 °C) = 35.9 °C, a result near to the one observed 
in this case. Taking the feverish dengue pattern into consideration once 
again4, or using the criterion suggested by NORMAN & YOSHIKAWA27, 
in which fever in the elderly is a body temperature increase of at least 2°F 
(1.1 °C) over baseline values, regardless of the measurement technique 
(oral, rectal, axillary or auricular), the patient did not present fever during 
hospitalization, which confirms the one-week evolution of the disease. 
Once the feverish period has ended, there is a possibility of 
hemorrhagical displays like epistaxes, petechias, gingivorrhagias, and 
maybe hematemesis, melena or hematuria15. That risk became more 
evident due to the ingestion of salicylate for two days2, which led to her 
hospitalization.
A final diagnostic hypothesis was due to the clinical profile and the 
evolution of the illness, either being classic dengue and/or complicated 
dengue due to the use of salicylate4,34. 
Few articles concerning dengue in the elderly were found. TAYLOR 
et al.32 (1987) and HALSTEAD15 (1994) discuss the increase of the 
elderly population in dengue-endemic areas. These authors consider 
the association between the elderly and dengue a public health problem, 
because there are high necessities of health assistance in that age range 
and severe degrees of morbidity and death by the disease. It is important 
to observe that the elderly, when retired or a widow/widower, as in the 
case reported, tend to live in seaside/warmer cities, which are prone to 
the development of dengue epidemics. 
MATTOS-ALMEIDA et al.23 (2007) emphasize the fact that the 
elderly and children, who tend to stay at home longer, are more exposed 
to Aedes aegypti than other age groups. YAMASHIRO et al.39 (2004) 
and IMRIE et al.14 (2007) found a high percentage of specific IgG to 
the dengue virus in the cases of patients who were over 60 years old. 
Other studies confirmed the same occurrence of different serotypes and 
related it to expressive percentages of severe dengue with hemorrhage 
and/or shock10,13,20,21. Adding the high prevalence of chronic diseases to 
that age range, which increased hospitalizations and mortality10,13,20,21. 
Considering that the patient moved to the city of Ubatuba two years 
before this case report, there is a possibility that it was her first infection, 
which is probably why complications were not so severe, and suggests 
salicylate as the stimulating factor for hemorrhages.
The scarce literature concerning dengue and the elderly is also reflected 
in the number of cases reported individually1,6,17,18,24,26,35, usually published 
due to their rare complications and not explained by the patients’ age (Table 
2). Only one of these cases described an 80-year old woman35. 
Two descriptions of the ingestion of acetylsalicylic acid during a 
dengue infection were found in the sources looked up. When reporting the 
hospitalization of 24 American soldiers in the Philippines, all between 20 
and 43 years old, HAYES et al.16 (1989) discussed a case that developed to 
shock and high digestive hemorrhage because of the use of salicylate. The 
other publication34 describes the case of a 50 year-old Catalan lady who, 
after traveling to the Caribbean, developed a classic dengue condition 
with signs of probable hemorrhagic dengue fever degree I, caused by 
acetylsalicylic acid. According to the authors of the article34, the elderly 
woman had reported taking salicylate on her own account, which also 
occurred with the patient being reported in this essay. The elderly tend to 
take unprescribed medications, especially analgesics and antipyretics30, 
a fact that should be considered in endemic dengue areas.
Although more elderly populations are exposed to the risk of getting 
dengue, the clinical peculiarities of this disease in this age range are 
not well known, and that motivated this report. Literature consulted 
indicates more serious clinical conditions, higher hospitalization rates 
and significant mortality. This was caused by previous infections by 
other serotypes of this arbovirus, the presence of chronic diseases, 
immunosenescence, and high drug consumption, especially salicylates 
and the like. Analyses are required in a public health perspective in order 
to help health professionals who care for elderly patients with dengue. 
RESUMO
Dengue em paciente idosa 
Embora cada vez mais populações idosas estejam expostas ao 
risco de contrair dengue, pouco se sabe sobre peculiaridades clínicas 
desta doença nesta faixa etária, fato este que motivou este relato sobre 
Table 2
Cases of dengue in patients over 60 years old. The publications took place due to their rare complications, and not because of the patients’ age
Author(s) Publication year Age (years) Gender Clinical condition Evolution




Meningism Encephalitis + shock Remission
Death
NOGUEIRA et al.26 2002 67 Male Encephalitis Remission
HORTA VELOSO et al.17 2003 61 Male Myocarditis + Atrial fibrillation Remission
CHEN et al.6 2004 66 Female Pancreatitis Remission
McBRIDE24 2005 70 Male Melena + shock Death
BASÍLIO-DE-OLIVEIRA et al.1 2005 63 Male Dengue hemorrhagic fever + shock Death
KARAKUS et al.18 2007 66 Male Rhabdomyolysis + shock Death
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octogenária com dengue agravada por automedicação de salicilato. A 
literatura consultada aponta para quadro clínico mais grave, elevado 
índice de hospitalizações e mortalidade significativa. Deve-se isto a 
infecções prévias com outros sorotipos desta arbovirose, presença de 
doenças crônico degenerativas, imunosenescência e alto consumo de 
medicamentos, particularmente salicilatos e similares. Análises, sob a 
ótica da saúde pública, são necessárias para auxiliar aos profissionais de 
saúde que assistem pacientes com dengue nesta faixa etária.
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